study_id;sex;age_year;age_month;age_group;tumor_type_grouped;tumor_level3;tumor_level2;tumor_level1;tumor_level0;metastasis;neuroblastoma_risk;one_PFS;death;tmb;tmb_group;baseline;cytof_barcode_id;cytof_batch;olink_id;olink_batch;mRNA_barcode_id;NGI_id;mRNA_batch;Tumor_Sample_Barcode;tumor_occassion;WGS_data_version
1;Female;0;1,798611111;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;NA;NA;TRUE;8310;EXP-19-CL8767;4657;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1033;P12901;NA;NA;NA
2;Male;1;22,86666667;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;high;TRUE;FALSE;0,837988827;high;TRUE;8312;EXP-19-CL8767;4663;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1051;P12901;P26657_131;Primary;old
3;Female;16;198,2652778;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,139664804;low;TRUE;8315;EXP-19-CL8767;4669;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1046;P12901;P24126_156;Primary;old
4;Female;6;79,36666667;children (6-11 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;FALSE;FALSE;NA;NA;TRUE;8316;EXP-19-CL8767;4671;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1047;P12901;NA;NA;NA
5;Female;10;121,3333333;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,30726257;low;TRUE;8320;EXP-20-CL8798;4679;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1054;P12901;P24126_157;Primary;old
6;Female;5;70,43333333;young children (2-5 years);Brain tumor;Anaplastic Ependymoma;Ependymoma;Ependymal tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0,167597765;low;TRUE;8321;EXP-19-CL8767;4681;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1055;P12901;P13714_132;Primary;old
7;Male;13;158,5;adolescents (12-17 years);Liver tumor;Hepatocellular cancer;Hepatocellular cancer;Liver tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;8322;EXP-18-CL8730;4683;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1095;P12901;NA;NA;NA
8;Male;8;96,36666667;children (6-11 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,223463687;low;TRUE;8324;EXP-19-CL8767;4687;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1056;P12901;P20910_101;Primary;old
10;Male;11;132,8666667;children (6-11 years);Brain tumor;Meningioma;Meningioma;Meningioma;Intra Cranial Tumor;NA;NA;TRUE;TRUE;0,223463687;low;TRUE;8327;EXP-19-CL8767;4693;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1183;P12901;P26657_106;Primary;old
11;Female;1;23,9;infants (1-24 months);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0,251396648;low;TRUE;8328;EXP-18-CL8730;4695;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1063;P12901;P13714_156;Primary;old
13;Male;14;176,1319444;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;8333;EXP-18-CL8730;4705;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1068;P12901;NA;NA;NA
14;Male;10;130,3666667;children (6-11 years);Lymphoma;Nodular lymphocyte predominant Hodgkin lymphoma;Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;8335;EXP-19-CL8767;4709;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1070;P12901;NA;NA;NA
15;Male;10;126,7652778;children (6-11 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;8337;EXP-19-CL8767;4713;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1072;P12901;NA;NA;NA
17;Female;5;62,56666667;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,279329609;low;TRUE;8340;EXP-18-CL8730;4721;Plate1_INF_ISAC5_Brodin_210706;NA;P12901_1185;P12901;P24126_158;Primary;old
18;Male;8;103,2652778;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,391061453;low;TRUE;8343;EXP-19-CL8767;4727;Plate1_IMONC_ISAC_Brodin_221004;NA;P12901_1075;P12901;P25501_116;Primary;old
19;Male;4;57,89861111;young children (2-5 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,251396648;low;TRUE;8344;EXP-19-CL8767;4729;Plate1_IMONC_ISAC_Brodin_221004;NA;P12901_1188;P12901;P19060_123;Primary;old
20;Male;0;6,665277778;infants (1-24 months);Retinoblastoma;Retinoblastoma bilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;FALSE;FALSE;NA;NA;TRUE;8346;EXP-19-CL8767;4733;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1077;P12901;NA;NA;NA
21;Male;4;56,26666667;young children (2-5 years);Lymphoma;T lymphoblastic lymphoma;T lymphoblastic lymphoma;Lymphoma;Others;TRUE;NA;TRUE;TRUE;0,642458101;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P24126_159;Primary;old
22;Male;15;183,9;adolescents (12-17 years);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,335195531;low;TRUE;8348;EXP-19-CL8767;4739;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1189;P12901;P21815_106;Primary;old
23;Female;9;115,6319444;children (6-11 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;7531;EXP-19-CL8767;4743;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1079;P12901;NA;NA;NA
24;Male;1;15,4;infants (1-24 months);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,195530726;low;TRUE;7533;EXP-19-CL8767;4745;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1080;P12901;P26657_152;Primary;old
25;Male;14;179,3986111;adolescents (12-17 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,893854749;high;TRUE;7545;EXP-19-CL8767;4747;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1081;P12901;P13714_125;Primary;old
26;Female;14;171,0666667;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;0,30726257;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_132;Primary;old
27;Male;1;12,26666667;infants (1-24 months);Retinoblastoma;Retinoblastoma bilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;FALSE;FALSE;NA;NA;TRUE;7543;EXP-19-CL8767;4755;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1113;P12901;NA;NA;NA
28;Female;5;60,9;young children (2-5 years);Brain tumor;Medulloblastoma SHH (p53 WT/mut);Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,335195531;low;FALSE;NA;NA;NA;NA;NA;NA;NA;810T;Primary;old
28;Female;5;60,9;young children (2-5 years);Brain tumor;Medulloblastoma SHH (p53 WT/mut);Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0.47486034;;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_124;Relapse;old
30;Male;6;73,26666667;children (6-11 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0,195530726;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_104;Primary;old
30;Male;6;73,26666667;children (6-11 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0.64245810;;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_105;Relapse;old
31;Male;7;94,23333333;children (6-11 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;TRUE;TRUE;0,61452514;high;TRUE;7511;EXP-20-CL8798;2569;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1119;P12901;P26101_122;Primary;old
32;Female;0;3,401388889;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;low;NA;FALSE;NA;NA;TRUE;7513;EXP-20-CL8799;2571;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;NA;NA;NA;NA;NA
33;Female;17;206,1;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;7519;EXP-20-CL8798;2546;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1120;P12901;NA;NA;NA
34;Female;1;22,63333333;infants (1-24 months);Soft tissue sarcoma;Alveolar rhabdomyosarcoma;Alveolar rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;17;EXP-20-CL8798;2655;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1121;P12901;NA;NA;NA
35;Female;6;76,30138889;children (6-11 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;TRUE;NA;FALSE;FALSE;0,474860335;high;TRUE;18;EXP-19-CL8767;2656;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1122;P12901;P25501_133;Primary;old
36;Male;17;213,1013889;adolescents (12-17 years);Brain tumor;Other embryonal tumors;Other embryonal tumors;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;25;EXP-19-CL8767;2657;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1123;P12901;NA;NA;NA
37;Male;13;158,6666667;adolescents (12-17 years);Brain tumor;Glioblastoma multiforme (grade IV);Glioblastoma multiforme (grade IV);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;1,675977654;high;TRUE;75;EXP-20-CL8798;2665;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P12901_1125;P12901;P24125_105;Primary;old
38;Female;17;210,0013889;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;TRUE;NA;TRUE;FALSE;NA;NA;TRUE;86;EXP-19-CL8767;2706;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1126;P12901;NA;NA;NA
39;Male;7;89,60138889;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,083798883;low;TRUE;66;EXP-19-CL8767;2675;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1127;P12901;P13714_126;Primary;old
39;Male;7;89,60138889;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0.30726257;;TRUE;66;EXP-19-CL8767;2675;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;P12901_1127;P12901;P26101_107;Relapse;old
40;Female;1;20,00138889;infants (1-24 months);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,30726257;low;TRUE;61;EXP-19-CL8767;2663;Plate1_IMONC_PetterBrodin_solidtumors_190909;NA;NA;NA;P24126_104;Primary;old
46;Male;0;6,966666667;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;FALSE;FALSE;0,028;low;FALSE;NA;NA;NA;NA;NA;NA;NA;1149T;Primary;old
48;Female;5;62,9;young children (2-5 years);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,083798883;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_127;Primary;old
49;Male;3;36,43333333;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,30726257;low;TRUE;118;EXP-20-CL8799;2834;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19406_1047;Juno_P19406;P27307_102;Primary;old
50;Male;13;162,7347222;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,027932961;low;TRUE;134;EXP-20-CL8799;2800;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1037;Juno_P19207;P13714_128;Primary;old
51;Female;7;86,53333333;children (6-11 years);Brain tumor;Medulloblastoma WNT;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,279329609;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_129;Primary;old
52;Male;9;115,8;children (6-11 years);Brain tumor;Glioblastoma multiforme (grade IV);Glioblastoma multiforme (grade IV);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;346,8435754;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_105;Primary;old
55;Male;11;133,2333333;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,111731844;low;TRUE;181;EXP-20-CL8798;2883;Plate1_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19207_1041;Juno_P19207;P13714_130;Primary;old
56;Male;8;105,4013889;children (6-11 years);Lymphoma;Peripheral T cell lymphoma NOS (slaskgrupp);Peripheral T cell lymphoma NOS (slaskgrupp);Lymphoma;Others;TRUE;NA;TRUE;FALSE;0,921787709;high;TRUE;194;EXP-20-CL8798;2890;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1042;Juno_P19207;P25501_134;Primary;old
58;Male;14;172,8333333;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;0,055865922;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_135;Primary;old
59;Female;0;1,766666667;infants (1-24 months);Brain tumor;Atypical teratoid/rhabdoid tumor;Atypical teratoid/rhabdoid tumor;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,055865922;low;TRUE;NA;NA;2904;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;NA;NA;P26101_101;Primary;old
60;Male;0;7,734722222;infants (1-24 months);Liver tumor;Malignant rhabdoid tumor of the liver;Malignant rhabdoid tumor of the liver;Liver tumor;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;0,251396648;low;TRUE;244;EXP-20-DG3600;2954;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1045;Juno_P19207;P25501_136;Primary;old
60;Male;0;7,734722222;infants (1-24 months);Liver tumor;Malignant rhabdoid tumor of the liver;Malignant rhabdoid tumor of the liver;Liver tumor;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;1.39664804;;TRUE;244;EXP-20-DG3600;2954;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1045;Juno_P19207;1292-M1;Relapse;old
61;Female;11;132,7013889;children (6-11 years);Others;Extra cranial tumor other;Extra cranial tumor other;Rare tumors;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;248;EXP-20-DG3600;2956;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1046;Juno_P19207;NA;NA;NA
62;Male;0;3,633333333;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;0,167597765;low;TRUE;254;EXP-20-DG3600;2964;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19207_1047;Juno_P19207;P25501_126;Primary;old
65;Female;7;89,13194444;children (6-11 years);Soft tissue sarcoma;Embryonal rhabdomyosarcoma;Embryonal rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;271;EXP-20-CL8799;2995;Plate1_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19602_1002;Juno_P19602;NA;NA;NA
67;Female;14;173,4;adolescents (12-17 years);Germ cell tumors;Ovarian germ cell tumor;Ovarian germ cell tumor;Germ cell tumors;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,279329609;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P26101_131;Primary;old
72;Male;1;20,56666667;infants (1-24 months);Brain tumor;Medulloblastoma SHH (p53 WT/mut);Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,418994413;high;TRUE;478;EXP-20-DG3600;3203;Plate1_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1004;Juno_P19602;P19060_109;Primary;old
75;Female;3;47,23333333;young children (2-5 years);Soft tissue sarcoma;Angiosarcoma;Angiosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;0,391061453;low;TRUE;492;EXP-20-CL8799;3240;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19602_1005;Juno_P19602;P25501_137;Primary;old
77;Male;17;213,6652778;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;0,335195531;low;TRUE;521;EXP-20-DG3600;3291;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19602_1006;Juno_P19602;P25501_138;Primary;old
78;Male;2;34,73333333;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,30726257;low;TRUE;559;EXP-20-DG3600;3342;PP2020_0065_ONC;NA;NA;NA;P19061_101;Primary;old
79;Male;0;11,76666667;infants (1-24 months);Retinoblastoma;Retinoblastoma bilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;FALSE;FALSE;NA;NA;TRUE;577;EXP-20-DG3600;3381;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1007;Juno_P19602;NA;NA;NA
81;Female;3;42,06666667;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;FALSE;FALSE;NA;NA;TRUE;594;EXP-20-CL8798;3443;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1009;Juno_P19602;NA;NA;NA
82;Male;14;178,6986111;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;TRUE;NA;TRUE;FALSE;0,335195531;low;TRUE;605;EXP-20-CL8798;3465;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19602_1010;Juno_P19602;P25501_139;Primary;old
83;Female;10;123,9333333;children (6-11 years);Brain tumor;Medulloblastoma WNT;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;TRUE;0,391061453;low;TRUE;681;EXP-20-DG3600;3517;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1011;Juno_P19602;P20911_110;Primary;old
85;Male;7;95,7;children (6-11 years);Brain tumor;Meningioma;Meningioma;Meningioma;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,279329609;low;TRUE;699;EXP-20-DG3600;3552;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1013;Juno_P19602;P25501_106;Primary;old
86;Female;0;3,968055556;infants (1-24 months);Retinoblastoma;Retinoblastoma unilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;708;EXP-20-CL8799;3574;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1014;Juno_P19602;NA;NA;NA
87;Female;15;184,5013889;adolescents (12-17 years);Others;Extra cranial tumor other;Extra cranial tumor other;Rare tumors;Extra Cranial Tumor;TRUE;NA;FALSE;TRUE;NA;NA;TRUE;711;EXP-20-DG3600;3580;Plate2_IM-ONC_PetterBrodin_ISAC2_200204;NA;P19602_1015;Juno_P19602;NA;NA;NA
88;Male;15;186,5347222;adolescents (12-17 years);Brain tumor;Other embryonal tumors;Other embryonal tumors;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,279329609;low;TRUE;719;EXP-20-DG3600;3596;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1016;Juno_P19602;P19060_115;Primary;old
89;Male;0;0,1;neonates (0-30 days);Soft tissue sarcoma;Alveolar rhabdomyosarcoma;Alveolar rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;NA;NA;TRUE;721;EXP-20-DG3600;3600;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1017;Juno_P19602;NA;NA;NA
90;Male;12;155,2;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,195530726;low;TRUE;752;EXP-20-DG3600;3611;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1018;Juno_P19602;P19060_117;Primary;old
91;Male;0;4,1;infants (1-24 months);Brain tumor;Glioblastoma multiforme (grade IV);Glioblastoma multiforme (grade IV);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,055865922;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P19060_105;Primary;old
93;Female;4;49;young children (2-5 years);Brain tumor;Atypical teratoid/rhabdoid tumor;Atypical teratoid/rhabdoid tumor;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0,195530726;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P26101_102;Primary;old
93;Female;4;49;young children (2-5 years);Brain tumor;Atypical teratoid/rhabdoid tumor;Atypical teratoid/rhabdoid tumor;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0.27932961;;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_107;Relapse;old
94;Female;13;158,3;adolescents (12-17 years);Brain tumor;Other embryonal tumors;Other embryonal tumors;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;767;EXP-20-DG3600;3643;PP2020_0065_ONC;NA;P19602_1019;Juno_P19602;NA;NA;NA
99;Male;4;54,53472222;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,195530726;low;TRUE;860;EXP-20-CL8798;3742;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1023;Juno_P19602;P25501_140;Primary;old
100;Female;8;100,7;children (6-11 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;FALSE;TRUE;0,698324022;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P13714_149;Primary;old
102;Male;5;63,86666667;young children (2-5 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,726256983;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P19060_124;Primary;old
103;Male;5;61,46666667;young children (2-5 years);Brain tumor;Optical pathway glioma in NF-1;Optical pathway glioma in NF-1;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;888;EXP-20-DG3600;3811;PP2020_0065_ONC;NA;P19602_1024;Juno_P19602;NA;NA;NA
104;Male;17;210,2333333;adolescents (12-17 years);Liver tumor;Hepatocellular cancer;Hepatocellular cancer;Liver tumor;Extra Cranial Tumor;TRUE;NA;FALSE;TRUE;NA;NA;TRUE;896;EXP-20-DG3600;3821;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1025;Juno_P19602;NA;NA;NA
105;Female;13;157,4666667;adolescents (12-17 years);Liver tumor;Hepatocellular cancer;Hepatocellular cancer;Liver tumor;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;1,508379888;high;TRUE;901;EXP-20-DG3600;3837;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1026;Juno_P19602;P25501_141;Primary;old
106;Male;6;80,36805556;children (6-11 years);Brain tumor;Meningioma;Meningioma;Meningioma;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,055865922;low;TRUE;909;EXP-20-DG3600;3843;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;NA;NA;P19060_122;Primary;old
108;Female;0;8,468055556;infants (1-24 months);Retinoblastoma;Retinoblastoma unilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;935;EXP-20-DG3625;4085;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1027;Juno_P19602;NA;NA;NA
110;Male;1;21;infants (1-24 months);Brain tumor;Choroid plexus tumor;Choroid plexus tumor;Choroid plexus tumor;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,335195531;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P19060_113;Primary;old
111;Female;3;41,30138889;young children (2-5 years);Soft tissue sarcoma;Embryonal rhabdomyosarcoma;Embryonal rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;TRUE;NA;FALSE;TRUE;NA;NA;TRUE;1066;EXP-20-DG3625;4133;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1030;Juno_P19602;NA;NA;NA
112;Female;5;61,3;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;0,139664804;low;TRUE;1069;EXP-20-DG3625;4130;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P19602_1031;Juno_P19602;P26101_123;Primary;old
116;Male;14;171,6333333;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,30726257;low;TRUE;1081;EXP-20-DG3625;4162;PP2020_0065_ONC;NA;P19602_1034;Juno_P19602;P19060_116;Primary;old
117;Male;0;1,033333333;infants (1-24 months);Retinoblastoma;Retinoblastoma unilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;FALSE;FALSE;NA;NA;TRUE;1095;EXP-20-DG3625;4164;PP2020_0065_ONC;NA;P19602_1035;Juno_P19602;NA;NA;NA
118;Female;3;42,13333333;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;high;TRUE;FALSE;NA;NA;TRUE;1109;EXP-20-DG3625;4187;PP2020_0065_ONC;NA;P19602_1036;Juno_P19602;NA;NA;NA
119;Female;18;216,1333333;adults (18 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1117;EXP-20-DG3625;4203;PP2020_0065_ONC;NA;P19602_1037;Juno_P19602;NA;NA;NA
120;Male;1;18,53333333;infants (1-24 months);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,167597765;low;TRUE;1118;EXP-20-DG3625;4207;Plate2_IM-ONC_PetterBrodin_ISAC3_200903;NA;P22457_1004;Juno_P22457;P25501_142;Primary;old
121;Female;5;67,6;young children (2-5 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;0,251396648;low;TRUE;1119;EXP-20-DG3625;4184;PP2020_0065_ONC;NA;P19602_1038;Juno_P19602;P20909_106;Primary;old
122;Female;2;33,26666667;young children (2-5 years);Brain tumor;Medulloblastoma SHH (p53 WT/mut);Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,335195531;low;TRUE;1123;EXP-20-DG3625;4215;PP2020_0065_ONC;NA;P19602_1039;Juno_P19602;P19060_131;Primary;old
124;Female;18;216,8;adults (18 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1138;EXP-20-DG3625;4248;PP2020_0065_ONC;NA;P19602_1040;Juno_P19602;NA;NA;NA
125;Male;1;21,36666667;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;0,167597765;low;TRUE;1140;EXP-20-DG3625;4252;PP2020_0065_ONC;NA;P19602_1041;Juno_P19602;P25501_127;Primary;old
126;Female;9;117,0333333;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,363128492;low;TRUE;1143;EXP-20-DG3625;4258;PP2020_0065_ONC;NA;P19602_1042;Juno_P19602;P19060_118;Primary;old
127;Male;12;154,0666667;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,167597765;low;TRUE;1144;EXP-20-DG3625;4260;PP2020_0065_ONC;NA;P19602_1043;Juno_P19602;P19060_130;Primary;old
128;Female;3;43,63333333;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,167597765;low;TRUE;1149;EXP-20-DG3625;4272;PP2020_0065_ONC;NA;P19602_1044;Juno_P19602;P19060_132;Primary;old
129;Female;0;8,1;infants (1-24 months);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,223463687;low;TRUE;1150;EXP-20-DG3625;4274;PP2020_0065_ONC;NA;P19602_1045;Juno_P19602;P25501_143;Primary;old
130;Female;6;81,2;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,083798883;low;TRUE;1185;EXP-20-DG3625;4282;PP2020_0065_ONC;NA;P19602_1046;Juno_P19602;P19060_133;Primary;old
131;Female;8;102,9986111;children (6-11 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1187;EXP-20-DG3625;4295;PP2020_0065_ONC;NA;P19602_1047;Juno_P19602;NA;NA;NA
133;Male;5;69,4;young children (2-5 years);Brain tumor;Medulloblastoma WNT;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,865921788;high;TRUE;1248;EXP-20-DG3625;4539;PP2020_0065_ONC;NA;P22457_1006;Juno_P22457;P19060_125;Primary;old
134;Male;2;25,7;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;0,167597765;low;TRUE;1254;EXP-20-DG3625;4551;PP2020_0065_ONC;NA;NA;NA;P25501_128;Primary;old
135;Male;10;126,6986111;children (6-11 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;NA;NA;TRUE;1272;EXP-20-DG3625;4588;PP2020_0065_ONC;NA;P22457_1007;Juno_P22457;NA;NA;NA
137;Female;16;194,3;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1276;EXP-20-DG3625;4596;PP2020_0065_ONC;NA;P22457_1009;Juno_P22457;NA;NA;NA
138;Female;12;152,5319444;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1277;EXP-20-DG3625;4598;PP2020_0065_ONC;NA;P22457_1010;Juno_P22457;NA;NA;NA
141;Female;2;27,23333333;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;FALSE;TRUE;1,005586592;high;TRUE;1282;EXP-20-DG3625;4613;PP2020_0065_ONC;NA;P22457_1013;Juno_P22457;P26101_124;Primary;old
142;Female;11;133,9;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,335195531;low;TRUE;1297;EXP-20-DG3625;4649;PP2020_0065_ONC;NA;P22457_1015;Juno_P22457;P19061_105;Primary;old
143;Female;13;165,0986111;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1295;EXP-20-DG3625;4645;PP2020_0065_ONC;NA;P22457_1014;Juno_P22457;NA;NA;NA
144;Female;0;3,133333333;infants (1-24 months);Germ cell tumors;Teratoma;Teratoma;Germ cell tumors;Extra Cranial Tumor;FALSE;NA;FALSE;FALSE;0,083798883;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P19060_135;Primary;old
145;Male;15;192,7666667;adolescents (12-17 years);Brain tumor;Diffuse astrocytoma (grade II);Diffuse astrocytoma (grade II);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,474860335;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_108;Primary;old
146;Male;2;26,43333333;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,167597765;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_144;Primary;old
150;Male;3;37,76666667;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,083798883;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_145;Primary;old
151;Male;15;184,5680556;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1524;EXP-20-DG3625;4870;PP2020_0065_ONC;NA;P22457_1021;Juno_P22457;NA;NA;NA
152;Female;11;135,1680556;children (6-11 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;NA;NA;TRUE;1527;EXP-20-DG3625;4876;PP2020_0065_ONC;NA;P22457_1022;Juno_P22457;NA;NA;NA
153;Male;5;64,63472222;young children (2-5 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;1529;EXP-20-DG3625;4882;PP2020_0065_ONC;NA;P22457_1023;Juno_P22457;NA;NA;NA
155;Male;7;95,93333333;children (6-11 years);Soft tissue sarcoma;Embryonal rhabdomyosarcoma;Embryonal rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;1,089385475;high;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_146;Primary;old
156;Female;15;194;adolescents (12-17 years);Brain tumor;Other embryonal tumors;Other embryonal tumors;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,083798883;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P24126_109;Primary;old
157;Female;1;20,33472222;infants (1-24 months);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1546;EXP-21-DG3646;4912;Plate1_INF_ISAC5_Brodin_210706;NA;P22457_1027;Juno_P22457;NA;NA;NA
161;Male;14;179,9333333;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,139664804;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P24126_111;Primary;old
162;Male;13;165,3;adolescents (12-17 years);Brain tumor;Meningioma;Meningioma;Meningioma;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,363128492;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P24126_110;Primary;old
163;Male;11;137,1;children (6-11 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;1559;EXP-21-DG3646;4938;Plate1_INF_ISAC5_Brodin_210706;NA;P22457_1033;Juno_P22457;NA;NA;NA
166;Male;8;96,7;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,167597765;low;TRUE;1569;EXP-24-DV0739;4993;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P22457_1035;Juno_P22457;P24126_112;Primary;old
167;Female;5;63,03333333;young children (2-5 years);Germ cell tumors;Teratoma;Teratoma;Germ cell tumors;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;0,391061453;low;FALSE;NA;NA;NA;NA;NA;NA;NA;P25501_147;Primary;old
175;Female;15;181,6;adolescents (12-17 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;2063;EXP-21-DG3646;23339;Plate1_INF_ISAC5_Brodin_210706;NA;P22457_1043;Juno_P22457;NA;NA;NA
176;Female;12;155,5666667;adolescents (12-17 years);Brain tumor;Meningioma;Meningioma;Meningioma;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,083798883;low;TRUE;2412;EXP-24-DV0739;23835;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P22457_1044;Juno_P22457;GMSB-ST005T;Primary;new
178;Female;6;77,56666667;children (6-11 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;NA;NA;TRUE;2094;EXP-24-DV0739;23821;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P22457_1046;Juno_P22457;NA;NA;NA
181;Female;5;67,56666667;young children (2-5 years);Lymphoma;Nodular lymphocyte predominant Hodgkin lymphoma;Hodgkin lymphoma;Lymphoma;Others;TRUE;NA;TRUE;FALSE;NA;NA;TRUE;2425;EXP-24-DV0739;23847;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P22457_1048;Juno_P22457;NA;NA;NA
182;Female;13;159,7333333;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,111731844;low;TRUE;24811;EXP-24-DV0739;23869;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P26501_1045;Juno_P26501;ST004-2T;Primary;new
184;Male;1;18,66666667;infants (1-24 months);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,083798883;low;FALSE;NA;NA;NA;NA;NA;NA;NA;ST007T;Primary;new
185;Male;11;141,5;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,530726257;high;TRUE;24883;EXP-24-DV0739;23933;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11093;NA;NA;GMSB-ST021T;Primary;new
186;Male;2;25,7;young children (2-5 years);Brain tumor;Posterior fossa (EPN-PFA);Ependymoma;Ependymal tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,223463687;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST016T;Primary;new
187;Male;0;6,2;infants (1-24 months);Brain tumor;Medulloblastoma SHH (p53 WT/mut);Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,30726257;low;TRUE;24888;EXP-24-DV0739;23937;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11097;NA;NA;GMSB-ST014T;Primary;new
191;Female;2;24,7;young children (2-5 years);Brain tumor;Posterior fossa (EPN-PFA);Ependymoma;Ependymal tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,167597765;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST015T;Primary;new
192;Male;16;202,3;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;24935;EXP-24-DV0739;23994;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;P24001_1045;Juno_P24001;NA;NA;NA
193;Male;12;157,2333333;adolescents (12-17 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,977653631;high;TRUE;24941;EXP-24-DV0739;24006;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;NA;NA;GMSB-ST013T;Primary;new
195;Male;8;105,0333333;children (6-11 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,30726257;low;TRUE;24977;EXP-24-DV0739;24063;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11163;NA;NA;GMSB-ST019T;Primary;new
196;Male;11;141,1;children (6-11 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,921787709;high;TRUE;24988;EXP-24-DV0739;24085;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11174;NA;NA;GMSB-ST020T;Primary;new
197;Female;3;44,46666667;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,335195531;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST017T;Primary;new
198;Female;5;67,1;young children (2-5 years);Brain tumor;Optical pathway glioma in NF-1;Optical pathway glioma in NF-2;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,055865922;low;FALSE;NA;NA;NA;NA;NA;NA;NA;ST023T;Primary;new
201;Male;15;182,6666667;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,586592179;high;FALSE;NA;NA;NA;NA;NA;NA;NA;ST026T;Primary;new
203;Female;0;4,1;infants (1-24 months);Retinoblastoma;Retinoblastoma bilateral;Retinoblastoma;Retinoblastoma;Extra Cranial Tumor;FALSE;NA;NA;FALSE;NA;NA;TRUE;1986;EXP-24-DV0739;25452;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;NA;NA;NA;NA;NA
204;Male;6;82,83333333;children (6-11 years);Brain tumor;Optical pathway glioma in NF-1;Optical pathway glioma in NF-1;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;2015;EXP-24-DV0739;25504;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11294;NA;NA;NA;NA;NA
206;Female;7;89,76666667;children (6-11 years);Lymphoma;Burkitt lymphoma;Burkitt lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;1,340782123;high;TRUE;1786;EXP-24-DV0739;NA;NA;11308;NA;NA;GMSB-ST030T;Primary;new
207;Female;8;104,3;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,167597765;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST035T;Primary;new
208;Female;3;46,36666667;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;high;TRUE;FALSE;1,731843575;high;TRUE;1823;EXP-24-DV0739;25602;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11343;NA;NA;ST031T;Primary;new
209;Male;2;28,3;young children (2-5 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;0,558659218;high;TRUE;25153;EXP-24-DV0739;25634;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;NA;NA;GMSB-ST033T;Primary;new
210;Male;1;16,13333333;infants (1-24 months);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,083798883;low;TRUE;25157;EXP-24-DV0739;25642;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11362;NA;NA;GMSB-ST040T;Primary;new
212;Male;4;57,6;young children (2-5 years);Soft tissue sarcoma;Embryonal rhabdomyosarcoma;Embryonal rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,782122905;high;FALSE;NA;NA;NA;NA;NA;NA;NA;ST042T;Primary;new
219;Female;1;19,46666667;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;low;TRUE;FALSE;NA;NA;TRUE;27412;EXP-24-DV0739;25788;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11444;NA;NA;NA;NA;NA
220;Female;14;172,0333333;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;27419;EXP-24-DV0739;25820;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11451;NA;NA;NA;NA;NA
222;Female;13;161,2666667;adolescents (12-17 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,418994413;high;TRUE;27426;EXP-24-DV0739;25834;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11458;NA;NA;GMSB-ST052T;Primary;new
224;Male;14;179,4333333;adolescents (12-17 years);Lymphoma;Anaplastic large cell lymphoma (ALK positive);Anaplastic large cell lymphoma ALK positive;Lymphoma;Others;TRUE;NA;FALSE;FALSE;0,586592179;high;TRUE;27439;EXP-24-DV0739;25878;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;20151;NA;NA;GMSB-ST046T;Primary;new
227;Male;3;44,5;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,61452514;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST053T;Primary;new
229;Female;1;22,16666667;infants (1-24 months);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,167597765;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST056T;Primary;new
230;Male;10;122,1333333;children (6-11 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;27462;EXP-24-DV0739;25925;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11495;NA;NA;NA;NA;NA
234;Male;7;90,9;children (6-11 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,893854749;high;TRUE;27478;EXP-24-DV0739;25957;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;NA;NA;GMSB-ST059T;Primary;new
236;Male;10;122,9333333;children (6-11 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;1,731843575;high;TRUE;27638;EXP-24-DV0739;26145;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11548;NA;NA;GMSB-ST061T;Primary;new
237;Female;6;81,6;children (6-11 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,418994413;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST062T;Primary;new
239;Female;3;47,63333333;young children (2-5 years);Brain tumor;Posterior fossa (EPN-PFA);Ependymoma;Ependymal tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,391061453;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST066T;Primary;new
240;Female;9;112,3333333;children (6-11 years);Soft tissue sarcoma;Alveolar rhabdomyosarcoma;Alveolar rhabdomyosarcoma;Soft tissue sarcoma;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;NA;NA;TRUE;27669;EXP-24-DV0739;NA;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11561;NA;NA;NA;NA;NA
243;Male;16;194,4666667;adolescents (12-17 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,726256983;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST054T;Primary;new
245;Female;3;39,2;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,167597765;low;TRUE;28598;EXP-24-DV0739;27105;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11604;NA;NA;GMSB-ST072T;Primary;new
246;Female;3;41,13333333;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,251396648;low;TRUE;28597;EXP-24-DV0739;27103;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11600;NA;NA;GMSB-ST071T;Primary;new
247;Male;6;76,13333333;children (6-11 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;0,977653631;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST068T;Primary;new
248;Female;13;168,1;adolescents (12-17 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;28605;EXP-24-DV0739;27119;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11610;NA;NA;NA;NA;NA
254;Female;15;186,0666667;adolescents (12-17 years);Lymphoma;Classical Hodgkin lymphoma (Nodular sclerosis);Hodgkin lymphoma;Lymphoma;Others;FALSE;NA;TRUE;FALSE;NA;NA;TRUE;29243;EXP-24-DV0739;38749;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;11647;NA;NA;NA;NA;NA
255;Female;3;43,43333333;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,418994413;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST086T;Primary;new
257;Male;1;17,7;infants (1-24 months);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;FALSE;NA;NA;TRUE;29251;EXP-24-DV0739;38777;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;NA;NA;NA;NA;NA;NA
258;Female;7;87,53333333;children (6-11 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;FALSE;TRUE;0,251396648;low;TRUE;29252;EXP-24-DV0739;39153;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12249;NA;NA;GMSB-ST090T;Primary;new
262;Female;4;53,43333333;young children (2-5 years);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;NA;NA;TRUE;38019;EXP-24-DV0739;39510;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12300;NA;NA;NA;NA;NA
265;Male;4;59,83333333;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,502793296;high;TRUE;38027;EXP-24-DV0739;39526;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12340;NA;NA;GMSB-ST113T;Primary;new
268;Male;1;12,66666667;infants (1-24 months);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,279329609;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST116T;Primary;new
269;Female;5;63,13333333;young children (2-5 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;TRUE;FALSE;9,357541899;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST121T;Primary;new
270;Female;0;11,86666667;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;high;TRUE;FALSE;6,759776536;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST126T;Primary;new
271;Female;15;187,9666667;adolescents (12-17 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;FALSE;TRUE;1,005586592;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST130T;Primary;new
273;Male;3;42,5;young children (2-5 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;TRUE;FALSE;0,223463687;low;TRUE;42975;EXP-24-DV0739;39632;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12386;NA;NA;GMSB-ST129T;Primary;new
274;Female;1;20,56666667;infants (1-24 months);Liver tumor;Hepatoblastoma;Hepatoblastoma;Liver tumor;Extra Cranial Tumor;TRUE;NA;TRUE;FALSE;NA;NA;TRUE;42976;EXP-24-DV0739;39628;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;20120;NA;NA;NA;NA;NA
275;Male;10;131,8666667;children (6-11 years);Lymphoma;T lymphoblastic lymphoma;T lymphoblastic lymphoma;Lymphoma;Others;TRUE;NA;TRUE;FALSE;NA;NA;TRUE;38046;EXP-24-DV0739;39573;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12366;NA;NA;NA;NA;NA
277;Male;6;84,6;children (6-11 years);Lymphoma;T lymphoblastic lymphoma;T lymphoblastic lymphoma;Lymphoma;Others;TRUE;NA;TRUE;FALSE;0,558659218;high;TRUE;42979;EXP-24-DV0739;39581;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12370;NA;NA;GMSB-ST131T;Primary;new
279;Female;9;118,6333333;children (6-11 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,195530726;low;TRUE;42956;EXP-24-DV0739;39646;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12726;NA;NA;GMSB-ST133T;Primary;new
281;Female;10;124,6333333;children (6-11 years);Brain tumor;Ganglioglioma;Ganglioglioma;Neuronal and mixed neuronal-glial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;NA;NA;TRUE;42960;EXP-24-DV0739;39660;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12733;NA;NA;NA;NA;NA
282;Male;13;160,2;adolescents (12-17 years);Brain tumor;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse midline glioma (incl DIPG) H3K27 mutant;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,810055866;high;TRUE;42961;EXP-24-DV0739;39662;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12734;NA;NA;GMSB-ST136T;Primary;new
283;Male;15;190,0666667;adolescents (12-17 years);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;TRUE;NA;NA;FALSE;0,335195531;low;TRUE;43641;EXP-24-DV0739;40078;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12757;NA;NA;GMSB-ST139T;Primary;new
285;Male;7;93,7;children (6-11 years);Brain tumor;Medulloblastoma Group3/Group4;Medulloblastoma;Embryonal tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,670391061;high;TRUE;43594;EXP-24-DV0739;40086;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12772;NA;NA;GMSB-ST143T;Primary;new
286;Male;3;46,43333333;young children (2-5 years);Germ cell tumors;Germ cell tumor;Germ cell tumor;Germ cell tumors;Extra Cranial Tumor;FALSE;NA;NA;FALSE;0,921787709;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST146T;Primary;new
290;Male;0;10,8;infants (1-24 months);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;FALSE;high;NA;FALSE;1,368715084;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST153T;Primary;new
294;Female;14;173;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;2,067039106;high;TRUE;43603;EXP-24-DV0739;40262;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12878;NA;NA;GMSB-ST156T;Primary;new
297;Female;9;108,5333333;children (6-11 years);Neuroblastoma;Neuroblastoma;Neuroblastoma;Neuroblastoma;Extra Cranial Tumor;TRUE;high;TRUE;FALSE;1,117318436;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST063T;Primary;new
298;Male;10;130,8333333;children (6-11 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;0,335195531;low;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST163T;Primary;new
299;Female;15;186,2;adolescents (12-17 years);Lymphoma;B lymphoblastic lymphoma;B lymphoblastic lymphoma;Lymphoma;Others;FALSE;NA;NA;FALSE;NA;NA;TRUE;43634;EXP-24-DV0739;40367;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12917;NA;NA;NA;NA;NA
300;Female;5;72,96666667;young children (2-5 years);Brain tumor;Optical pathway glioma in NF-1;Optical pathway glioma in NF-1;Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;NA;NA;TRUE;48819;EXP-24-DV0739;40369;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12918;NA;NA;NA;NA;NA
302;Female;4;59,36666667;young children (2-5 years);Kidney tumor;Wilms tumor unilateral;Wilms tumor;Kidney tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;NA;NA;TRUE;48781;EXP-24-DV0739;NA;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12926;NA;NA;NA;NA;NA
303;Male;3;38,83333333;young children (2-5 years);Brain tumor;Pilocytic astrocytoma (grade I);Pilocytic astrocytoma (grade I);Diffuse astrocytic and oligodenroglial tumors;Intra Cranial Tumor;NA;NA;NA;FALSE;0,167597765;low;TRUE;48782;EXP-24-DV0739;40375;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12927;NA;NA;GMSB-ST173T;Primary;new
304;Male;17;211,7666667;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;1,117318436;high;TRUE;48784;EXP-24-DV0739;40379;Plate1_IO_LindaLjungblad_PediatricSolidTumor_240207_SA;12943;NA;NA;GMSB-ST169T;Primary;new
315;Female;14;172,0333333;adolescents (12-17 years);Bone tumor;Osteosarcoma;Osteosarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;1,56424581;high;FALSE;NA;NA;NA;NA;NA;NA;NA;GMSB-ST190T;Primary;new
317;Female;3;47;young children (2-5 years);Liver tumor;Malignant rhabdoid tumor of the liver;Malignant rhabdoid tumor of the liver;Liver tumor;Extra Cranial Tumor;FALSE;NA;NA;FALSE;0,195530726;low;FALSE;NA;NA;NA;Plate1_IMONC;NA;NA;NA;GMSB-ST191T;Primary;new
329;Female;1;13,76666667;infants (1-24 months);Bone tumor;Ewing sarcoma;Ewing sarcoma;Bone tumor;Extra Cranial Tumor;FALSE;NA;TRUE;FALSE;0,223463687;low;TRUE;NA;NA;NA;Plate1_IMONC;NA;NA;NA;GMSB-ST162T;Primary;new